UBS Group AG - BIOAFFINITY TECHNOLOGIES INC ownership

BIOAFFINITY TECHNOLOGIES INC's ticker is and the CUSIP is 09076W109. A total of 7 filers reported holding BIOAFFINITY TECHNOLOGIES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BIOAFFINITY TECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$76
-56.3%
65
-31.6%
0.00%
Q2 2023$174
-96.2%
95
-96.1%
0.00%
Q1 2023$4,553
-56.8%
2,409
-63.4%
0.00%
Q4 2022$10,530
-24.8%
6,581
+33.7%
0.00%
Q3 2022$14,0004,9230.00%
Other shareholders
BIOAFFINITY TECHNOLOGIES INC shareholders Q3 2022
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 25$00.00%
Creative Planning 29,545$86,0000.00%
ROYAL BANK OF CANADA 1$00.00%
JANE STREET GROUP, LLC 11,004$32,0000.00%
UBS Group AG 4,923$14,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Citadel Advisors 20,583$60,0000.00%
View complete list of BIOAFFINITY TECHNOLOGIES INC shareholders